Purchase by Lux Venture Partners V, LLC / Josh Wolfe / Peter Hebert / Lux Ventures V, L.P. / Lux Co-Invest Opportunities II, L.P. / Lux Total Opportunities, L.P.
Eikon Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $10.79
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS